Heartland Advisors Inc. lifted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 40.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 611,722 shares of the medical instruments supplier’s stock after purchasing an additional 175,383 shares during the quarter. […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Based on an average daily trading volume, of 336,700 shares, the […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Currently, 2.0% of the shares of the company are sold short. Based on an […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a decrease of 18.2% from the March 31st total of 923,300 shares. Approximately 2.0% of the company’s stock are short sold. Based on […]
Raymond James downgraded shares of AngioDynamics (NASDAQ:ANGO – Get Rating) from a strong-buy rating to an outperform rating in a report released on Monday morning, Marketbeat.com reports. The brokerage currently has $13.00 price target on the medical instruments supplier’s stock, down from their previous price target of $14.00. Separately, StockNews.com assumed coverage on shares of […]